Teich T, Hu R, Nagy A, Shago M, et al. CDKN2A deletion in p16-negative/HPV-positive head and neck squamous cell carcinoma: Highlighting the molecular basis behind the limitation of relying on p16 immunohistochemistry as a surrogate marker for HPV involvement. Histopathology 2025 Oct 9. doi: 10.1111/his.70021.
PMID: 41064927